MDM2 SNP309 and p53 Codon 72 Genetic Polymorphisms and Risk of AML: An Egyptian Study

被引：0
|
作者：
ZainabElsaadany [1 ]
El-Danasouri, Nabil [1 ]
Nabil, Safa [2 ]
机构：
[1] Cairo Univ, Giza, Egypt
[2] Natl Res Ctr, Cairo, Egypt
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-040
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [41] TP53 Arg 72Pro and MDM2 SNP309 Polymorphisms and Colorectal Cancer Risk: A West Algerian Population Study
    Abderrahmane, Rym
    Louhibi, Lotfi
    Moghtit, Fatima Zohra
    Boubekeur, Amina
    Benseddik, Khedidja
    Boudjema, Abdellah
    Benrrahal, Fouzia
    Aberkane, Meriem
    Fodil, Mostefa
    Saidi-Mehtar, Nadhira
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (03) : 629 - 635
  • [42] MDM2 SNP309 and risk of endometrial cancer REPLY
    Zajac, Agnieszka
    Stachowiak, Grzegorz
    Pertynski, Tomasz
    Romanowicz, Hanna
    Wilczynski, Jacek
    Smolarz, Beata
    POLISH JOURNAL OF PATHOLOGY, 2013, 64 (01) : 70 - 70
  • [43] MDM2 SNP309 and cancer risk: a combined analysis
    Wilkening, Stefan
    Bermejo, Justo Lorenzo
    Hemminki, Kari
    CARCINOGENESIS, 2007, 28 (11) : 2262 - 2267
  • [44] Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients
    Marjanka K Schmidt
    Johanna Tommiska
    Annegien Broeks
    Flora E van Leeuwen
    Laura J Van't Veer
    Paul DP Pharoah
    Douglas F Easton
    Mitul Shah
    Manjeet Humphreys
    Thilo Dörk
    Scarlett A Reincke
    Rainer Fagerholm
    Carl Blomqvist
    Heli Nevanlinna
    Breast Cancer Research, 11
  • [45] Mdm2 SNP309 and bladder cancer risk.
    Stoehr, Robert
    Hitzenbichler, Florian
    Hammerschmied, Christine
    Rogenhofer, Michael
    Hartmann, Arndt
    CANCER RESEARCH, 2009, 69
  • [46] No association of MDM2 SNP309 with risk of glioblastoma and prognosis
    Soufiane El Hallani
    Yannick Marie
    Ahmed Idbaih
    Mathieu Rodero
    Blandine Boisselier
    Florence Laigle-Donadey
    François Ducray
    Jean-Yves Delattre
    Marc Sanson
    Journal of Neuro-Oncology, 2007, 85 : 241 - 244
  • [47] MDM2 SNP309 and melanoma risk among women
    Firoz, E.
    Warycha, M. A.
    Shapiro, R. L.
    Berman, R. S.
    Kamino, H.
    Darvishian, F.
    Rolnitzky, L.
    Goldberg, J.
    Osman, I.
    Polsky, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] MDM2 SNP309 is associated with endometrial cancer risk
    Terry, Kathryn
    McGrath, Monica
    Lee, I-Min
    Buring, Julie
    De Vivo, Immaculata
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (04) : 983 - 986
  • [49] No association of MDM2 SNP309 with risk of glioblastoma and prognosis
    El Hallani, Soufiane
    Marie, Yannick
    Idbaih, Ahmed
    Rodero, Mathieu
    Boisselier, Blandine
    Laigle-Donadey, Florence
    Ducray, Francois
    Delattre, Jean-Yves
    Sanson, Marc
    JOURNAL OF NEURO-ONCOLOGY, 2007, 85 (03) : 241 - 244
  • [50] Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients
    Schmidt, Marjanka K.
    Tommiska, Johanna
    Broeks, Annegien
    van Leeuwen, Flora E.
    Van't Veer, Laura J.
    Pharoah, Paul D. P.
    Easton, Douglas F.
    Shah, Mitul
    Humphreys, Manjeet
    Dork, Thilo
    Reincke, Scarlett A.
    Fagerholm, Rainer
    Blomqvist, Carl
    Nevanlinna, Heli
    BREAST CANCER RESEARCH, 2009, 11 (06):
12345